Originally Posted by The Alchemist
That was posted on 26Apr. Within two days replicel posted a legal disclaimer disassociating themselves from the statement that was made. Clearly, replicel is not on board with what Tobin Smith wrote, regardless of whether they paid him or not. As i said, this appears to be a separate issue from their clinical trials.
Does everyone realize how little stock volume has been traded on this stock? Everyone is trying to hype this up as some type of stock scam and that replicel allowed news releases like this to bilk investors out of their hard earned money. Do you realize how little money is in this company? It's nothing. Peanuts. If true, It would be the most ridiculous, pointless and unambitious stock scam ever. Use your head
Finally, some common sense on this thread. I came -this- close to quitting this forum altogether in disgust, but these last few posts have been great. I think I will just make rather more judicious use of the ignore list, which currently consists of Scorpion, but is about to get a whole lot heavier.
That comment by Tobin explains the retraction. Even if nothing else had happened, that statement would draw the ire of the regulatory authorities, to say nothing of Replicel themselves.
To say a Phase I trial primarily aimed at safety is "days aware from a billion dollar cure for baldness" is patently false.
In addition the major holders of Replicel stock are either directions or senior managers of the company. They can't just slip stock trades under the radar, they have to make public disclosure. If they were caught ramping up the stock price, then selling before releasing bad results, they would go to jail. No exceptions.
I did have a thought last night - didn't Replicel inject into the bald temple regions? So unlike Aderans and Histogen which both injected into thinning regions, Replicel immediately put themselves behind the 8-ball in terms of efficacy measurements. It could well be that regrowth at 6 months from a single injection there is negligible anyway.
It all comes down to the fact that we are all guessing until we get the results. Even after we get the results, we'll be guessing to some extent in trying to interpret them (unless of course the results are "didn't work - shutting down the company").